Development of Lipid-shell and Polymer Core Nanoparticles with Water-soluble Salidroside for Anti-cancer Therapy
Overview
Chemistry
Molecular Biology
Authors
Affiliations
Salidroside (Sal) is a potent antitumor drug with high water-solubility. The clinic application of Sal in cancer therapy has been significantly restricted by poor oral absorption and low tumor cell uptake. To solve this problem, lipid-shell and polymer-core nanoparticles (Sal-LPNPs) loaded with Sal were developed by a double emulsification method. The processing parameters including the polymer types, organic phase, PVA types and amount were systemically investigated. The obtained optimal Sal-LPNPs, composed of PLGA-PEG-PLGA triblock copolymers and lipids, had high entrapment efficiency (65%), submicron size (150 nm) and negatively charged surface (-23 mV). DSC analysis demonstrated the successful encapsulation of Sal into LPNPs. The core-shell structure of Sal-LPNPs was verified by TEM. Sal released slowly from the LPNPs without apparent burst release. MTT assay revealed that 4T1 and PANC-1 cancer cell lines were sensitive to Sal treatment. Sal-LPNPs had significantly higher antitumor activities than free Sal in 4T1 and PANC-1 cells. The data indicate that LPNPs are a promising Sal vehicle for anti-cancer therapy and worthy of further investigation.
Gu J, Cai X, Raza F, Zafar H, Chu B, Yuan H Nanoscale Adv. 2024; .
PMID: 39355839 PMC: 11440374. DOI: 10.1039/d4na00625a.
Fabrication and characterization of salidroside W/O/W emulsion with sodium alginate.
Zhang Q, Wang Y, Li L, Song H, Wu H, Zhu B Food Chem X. 2024; 22:101260.
PMID: 38450386 PMC: 10915508. DOI: 10.1016/j.fochx.2024.101260.
Yasir B, Rahim A, Lallo S, Saito Y, Goto K, Rohman A Asian Pac J Cancer Prev. 2023; 24(10):3345-3352.
PMID: 37898837 PMC: 10770682. DOI: 10.31557/APJCP.2023.24.10.3345.
Gajbhiye K, Salve R, Narwade M, Sheikh A, Kesharwani P, Gajbhiye V Mol Cancer. 2023; 22(1):160.
PMID: 37784179 PMC: 10546754. DOI: 10.1186/s12943-023-01849-0.
Chrysin and chrysin-loaded nanocarriers induced immunogenic cell death on B16 melanoma cells.
Oliyapour Y, Dabiri S, Molavi O, Hejazi M, Davaran S, Jafari S Med Oncol. 2023; 40(10):278.
PMID: 37624439 DOI: 10.1007/s12032-023-02145-z.